The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey
Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly. Our objective was to estimate CD's impact on medical costs, lost earnings, work and school absences, health status, and health-rel...
Saved in:
Published in | Inflammatory bowel diseases Vol. 22; no. 5; pp. 1032 - 1041 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly. Our objective was to estimate CD's impact on medical costs, lost earnings, work and school absences, health status, and health-related quality of life (HRQOL) in the US and to compute current and forecasted national costs.
We used the nationally representative Medical Expenditure Panel Survey to match 539 respondents with CD to similar respondents without any inflammatory bowel disease (IBD). We estimated annual costs, work and school absences, and self-assessed health status. HRQOL was assessed by the SF-12 Physical Component Summary and Mental Component Summary (PCS and MCS) scores. CD prevalence rates, population counts, and costs were used to forecast total national costs.
CD is associated with higher medical costs ($13,446 versus $6029) and lost earnings ($1249 versus $644) and is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025). Respondents with CD were more likely to miss work (38% versus 33%) or school (64% versus 33%), less likely to report being in excellent or very good physical health (24% versus 63%), and experienced lower HRQOL measured by the Physical Component Summary (43.4 versus 48.5) and Mental Component Summary (48.6 versus 50.0) than those without IBD.
CD is responsible for increased medical care costs and lower earnings, health status, and HRQOL. These data can serve as benchmarks when examining future CD-related costs and HRQOL. |
---|---|
AbstractList | BACKGROUNDApproximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly. Our objective was to estimate CD's impact on medical costs, lost earnings, work and school absences, health status, and health-related quality of life (HRQOL) in the US and to compute current and forecasted national costs.METHODSWe used the nationally representative Medical Expenditure Panel Survey to match 539 respondents with CD to similar respondents without any inflammatory bowel disease (IBD). We estimated annual costs, work and school absences, and self-assessed health status. HRQOL was assessed by the SF-12 Physical Component Summary and Mental Component Summary (PCS and MCS) scores. CD prevalence rates, population counts, and costs were used to forecast total national costs.RESULTSCD is associated with higher medical costs ($13,446 versus $6029) and lost earnings ($1249 versus $644) and is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025). Respondents with CD were more likely to miss work (38% versus 33%) or school (64% versus 33%), less likely to report being in excellent or very good physical health (24% versus 63%), and experienced lower HRQOL measured by the Physical Component Summary (43.4 versus 48.5) and Mental Component Summary (48.6 versus 50.0) than those without IBD.CONCLUSIONSCD is responsible for increased medical care costs and lower earnings, health status, and HRQOL. These data can serve as benchmarks when examining future CD-related costs and HRQOL. Background: Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly. Our objective was to estimate CD's impact on medical costs, lost earnings, work and school absences, health status, and health-related quality of life (HRQOL) in the US and to compute current and forecasted national costs. Methods: We used the nationally representative Medical Expenditure Panel Survey to match 539 respondents with CD to similar respondents without any inflammatory bowel disease (IBD). We estimated annual costs, work and school absences, and self-assessed health status. HRQOL was assessed by the SF-12 Physical Component Summary and Mental Component Summary (PCS and MCS) scores. CD prevalence rates, population counts, and costs were used to forecast total national costs. Results: CD is associated with higher medical costs ($13,446 versus $6029) and lost earnings ($1249 versus $644) and is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025). Respondents with CD were more likely to miss work (38% versus 33%) or school (64% versus 33%), less likely to report being in excellent or very good physical health (24% versus 63%), and experienced lower HRQOL measured by the Physical Component Summary (43.4 versus 48.5) and Mental Component Summary (48.6 versus 50.0) than those without IBD. Conclusions: CD is responsible for increased medical care costs and lower earnings, health status, and HRQOL. These data can serve as benchmarks when examining future CD-related costs and HRQOL. Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly. Our objective was to estimate CD's impact on medical costs, lost earnings, work and school absences, health status, and health-related quality of life (HRQOL) in the US and to compute current and forecasted national costs. We used the nationally representative Medical Expenditure Panel Survey to match 539 respondents with CD to similar respondents without any inflammatory bowel disease (IBD). We estimated annual costs, work and school absences, and self-assessed health status. HRQOL was assessed by the SF-12 Physical Component Summary and Mental Component Summary (PCS and MCS) scores. CD prevalence rates, population counts, and costs were used to forecast total national costs. CD is associated with higher medical costs ($13,446 versus $6029) and lost earnings ($1249 versus $644) and is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025). Respondents with CD were more likely to miss work (38% versus 33%) or school (64% versus 33%), less likely to report being in excellent or very good physical health (24% versus 63%), and experienced lower HRQOL measured by the Physical Component Summary (43.4 versus 48.5) and Mental Component Summary (48.6 versus 50.0) than those without IBD. CD is responsible for increased medical care costs and lower earnings, health status, and HRQOL. These data can serve as benchmarks when examining future CD-related costs and HRQOL. |
Author | Sugarman, Rebecca Hansen, Brian Bekker Ganz, Michael L Wang, Rosa Håkan-Bloch, Jonas |
Author_xml | – sequence: 1 givenname: Michael L surname: Ganz fullname: Ganz, Michael L organization: Evidera, Lexington, Massachusetts; and †Novo Nordisk A/S, Global Market Access, Søborg, Denmark – sequence: 2 givenname: Rebecca surname: Sugarman fullname: Sugarman, Rebecca – sequence: 3 givenname: Rosa surname: Wang fullname: Wang, Rosa – sequence: 4 givenname: Brian Bekker surname: Hansen fullname: Hansen, Brian Bekker – sequence: 5 givenname: Jonas surname: Håkan-Bloch fullname: Håkan-Bloch, Jonas |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26974852$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkT9PwzAQxS0EAgp8A4S8wZLi2I5js0EpUIk_EqVz5CYX1Sixi51W6sZHx1ULQizcDXcn_d674fXQrnUWEDpNST8lKr98Gt30ye_KOd1Bh2nGRMIl57txJ7lMiFLyAPVCeCeExlb76IAKlXOZ0UP0-TYDPCydda0psbYVfgDddLPEQ6M7qPConeuyw67GA-9m9jzgWxNAB8DG4i6KJ9asuXEX8XCFh0tTgS0B1961WONn3RlnddOs8CvMPQSwkTRLwOOFX8LqGO3Vuglwsp1HaHI3fBs8JI8v96PB9WNSUqm6ZFpLIjNJAUSmpiCV0lxTnot4c6GzKUm5ZoRzIWRdMVUyVtUyBc0op5Wo2BG62PjOvftYQOiK1oQSmkZbcItQpNFfqChX_6O5ZCqVjNGI8g1aeheCh7qYe9NqvypSUqxjKmJMxd-Youxs-2ExbaH6EX3nwr4ALWiOrw |
Cites_doi | 10.1046/j.1572-0241.2003.04010.x 10.1185/030079908X260790 10.1002/ibd.21371 10.1007/s10620-008-0670-7 10.1038/ajg.2012.298 10.1016/j.ahj.2003.10.039 10.1111/j.1365-2036.2009.03966.x 10.1371/journal.pone.0091059 10.1097/00005650-199603000-00003 10.1371/journal.pone.0134001 10.1136/gut.2010.234617 10.2307/145879 10.1038/ajg.2009.579 10.1111/j.1532-5415.2006.00681.x 10.1037/0003-066X.52.10.1051 10.1053/j.gastro.2011.10.001 10.3389/fpubh.2013.00015 10.1016/j.suc.2007.03.003 10.1097/MPG.0b013e318239bc79 10.1111/j.1463-1318.2005.00769.x 10.1093/wbro/11.1.23 10.1001/archpedi.158.9.884 10.1111/j.1475-6773.2005.00404.x 10.1007/s10620-012-2289-y 10.1007/s10620-012-2371-5 10.1097/MIB.0000000000000452 10.1097/01.mlr.0000208141.02083.86 10.1046/j.1365-2036.2002.01323.x 10.1097/MIB.0b013e3182a56148 10.1016/j.socscimed.2003.01.001 10.1016/S1570-677X(03)00035-2 10.1097/JOM.0b013e318181b8ca 10.1111/j.1572-0241.2007.01508.x 10.1053/j.gastro.2004.01.063 10.1097/MIB.0000000000000399 10.1053/j.gastro.2008.09.012 10.1007/s10620-014-3368-z 10.1097/MPG.0b013e31812f7f4e 10.1016/j.crohns.2013.01.010 10.1002/ibd.22916 10.1097/JOM.0b013e31827cba48 10.1038/ajg.2011.142 10.1097/01.MIB.0000438356.84263.3b 10.1001/archpedi.161.8.730 10.1111/1475-6773.12090 10.1001/archpedi.155.12.1346 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 H94 |
DOI | 10.1097/MIB.0000000000000742 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-4844 |
EndPage | 1041 |
ExternalDocumentID | 10_1097_MIB_0000000000000742 26974852 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .Z2 0R~ 1OC 31~ 3WU 4.4 48X 53G 5GY 5VS 5WD 66C 7O~ 8-0 8-1 8F7 8UM AAAXR AABZA AACZT AAJQQ AAKAS AAPGJ AAPQZ AAPXW AARHZ AARTV AASNB AAUAY AAUQX AAVAP AAWDT AAYEP ABBUW ABJNI ABNHQ ABOCM ABPQP ABPTD ABQNK ABWST ABXVJ ABXVV ABZAD ACDDN ACEWG ACFRR ACGFO ACGFS ACUTJ ACWDW ACWRI ACXNZ ACXQS ACYHN ACZBC ADBBV ADBIZ ADGZP ADIPN ADQBN ADRTK ADVEK ADZCM AENEX AETBJ AFBPY AFFZL AFOFC AFTRI AFUWQ AFXAL AFYAG AFZJQ AGINJ AGKRT AGMDO AGQXC AGUTN AHMBA AHRYX AIJEX AIZYK AJAOE AJEEA AJNYG ALMA_UNASSIGNED_HOLDINGS APJGH AQDSO AQKUS ATGXG AVNTJ AWKKM BAYMD BCRHZ BEYMZ BOYCO BTRTY C45 CDBKE CGR CS3 CUY CVF DAKXR DR2 DU5 E.X E3Z EBS ECM EIF EIHJH EJD ENERS EX3 F5P FECEO FL- FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H0~ H13 HZ~ IAO IHR IN~ ITC IX1 KBUDW KOP KSI KSN LAW LH4 LW6 MBLQV MHKGH NNB NOMLY NOYVH NPM NVLIB N~7 N~B O9- OAUYM OCUKA OCZFY ODMLO OIG OJZSN OPAEJ ORVUJ OVD OWPYF P2P PAFKI PQQKQ QRW ROL ROX RUSNO RX1 S4S TEORI TMA V2E W99 WOQ WOW XV2 Y6R YAYTL YKOAZ YXANX ZFV AAYXX CITATION 7X8 ABSAR 7T5 H94 |
ID | FETCH-LOGICAL-c289t-bf808582ee659be899a4a2476e6546a5b014a3044668fd39c33df81ea3242d6d3 |
ISSN | 1078-0998 |
IngestDate | Tue Aug 27 04:43:12 EDT 2024 Fri Aug 16 01:07:07 EDT 2024 Thu Sep 12 19:25:39 EDT 2024 Sat Sep 28 08:46:24 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c289t-bf808582ee659be899a4a2476e6546a5b014a3044668fd39c33df81ea3242d6d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26974852 |
PQID | 1783918332 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1808694669 proquest_miscellaneous_1783918332 crossref_primary_10_1097_MIB_0000000000000742 pubmed_primary_26974852 |
PublicationCentury | 2000 |
PublicationDate | 2016-May 2016-05-00 20160501 |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-May |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Inflammatory bowel diseases |
PublicationTitleAlternate | Inflamm Bowel Dis |
PublicationYear | 2016 |
References | Kappelman (R17-2-20160420) 2011; 17 Benjamins (R33-2-20160420) 2004; 59 Loftus (R46-2-20160420) 2011; 106 Haveman (R52-2-20160420) 1984; 19 Wyrwich (R49-2-20160420) 2004; 147 Schultz (R54-2-20160420) 2003; 1 Cohen (R25-2-20160420) 2002; 16 Ware (R31-2-20160420) 1996; 34 Lichtenstein (R11-2-20160420) 2004; 99 Vavricka (R58-2-20160420) 2013; 19 Gunnarsson (R19-2-20160420) 2012; 57 van Dyck (R23-2-20160420) 2004; 158 Thaler (R27-2-20160420) 2005; 7 Reynolds (R53-2-20160420) 2007; 161 Feagan (R26-2-20160420) 2007; 102 Bouguen (R59-2-20160420) 2011; 60 Loftus (R4-2-20160420) 2004; 126 Peyrin-Biroulet (R6-2-20160420) 2010; 105 Yu (R21-2-20160420) 2008; 24 Wilkins (R9-2-20160420) 2011; 84 Floyd (R10-2-20160420) 2015; 60 Fleishman (R38-2-20160420) 2006; 44 Szymanska (R57-2-20160420) 2014; 9 Behrman (R50-2-20160420) 1996; 11 Goodhand (R45-2-20160420) 2012; 18 Kappelman (R3-2-20160420) 2013; 58 Waters (R20-2-20160420) 2009; 54 deBruyn (R14-2-20160420) 2013; 19 Bombak (R34-2-20160420) 2013; 1 Koutsochristou (R56-2-20160420) 2015; 21 Burisch (R7-2-20160420) 2013; 7 Kappelman (R16-2-20160420) 2008; 135 Perrin (R28-2-20160420) 2008; 46 Kuhlthau (R22-2-20160420) 2001; 155 Peyrin-Biroulet (R12-2-20160420) 2012; 107 Gibson (R18-2-20160420) 2008; 50 Heaton (R15-2-20160420) 2012; 54 Dorr (R37-2-20160420) 2006; 54 Johannsen (R55-2-20160420) 2015; 10 Molodecky (R1-2-20160420) 2012; 142 Ephgrave (R8-2-20160420) 2007; 87 Zand (R13-2-20160420) 2015; 21 Dugoff (R40-2-20160420) 2014; 49 Ceci (R51-2-20160420) 1997; 52 Gunnarsson (R24-2-20160420) 2013; 55 DeSalvo (R36-2-20160420) 2005; 40 Burdine (R35-2-20160420) 2000; 35 Coteur (R47-2-20160420) 2009; 29 |
References_xml | – volume: 99 start-page: 91 year: 2004 ident: R11-2-20160420 publication-title: Am J Gastroenterol. doi: 10.1046/j.1572-0241.2003.04010.x contributor: fullname: Lichtenstein – volume: 24 start-page: 319 year: 2008 ident: R21-2-20160420 publication-title: Curr Med Res Opin. doi: 10.1185/030079908X260790 contributor: fullname: Yu – volume: 84 start-page: 1365 year: 2011 ident: R9-2-20160420 publication-title: Am Fam Physician. contributor: fullname: Wilkins – volume: 17 start-page: 62 year: 2011 ident: R17-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1002/ibd.21371 contributor: fullname: Kappelman – volume: 54 start-page: 2650 year: 2009 ident: R20-2-20160420 publication-title: Dig Dis Sci. doi: 10.1007/s10620-008-0670-7 contributor: fullname: Waters – volume: 35 start-page: 885 year: 2000 ident: R35-2-20160420 publication-title: Health Serv Res. contributor: fullname: Burdine – volume: 107 start-page: 1693 year: 2012 ident: R12-2-20160420 publication-title: Am J Gastroenterol. doi: 10.1038/ajg.2012.298 contributor: fullname: Peyrin-Biroulet – volume: 147 start-page: 615 year: 2004 ident: R49-2-20160420 publication-title: Am Heart J. doi: 10.1016/j.ahj.2003.10.039 contributor: fullname: Wyrwich – volume: 29 start-page: 1032 year: 2009 ident: R47-2-20160420 publication-title: Aliment Pharmacol Ther. doi: 10.1111/j.1365-2036.2009.03966.x contributor: fullname: Coteur – volume: 9 start-page: e91059 year: 2014 ident: R57-2-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0091059 contributor: fullname: Szymanska – volume: 34 start-page: 220 year: 1996 ident: R31-2-20160420 publication-title: Med Care. doi: 10.1097/00005650-199603000-00003 contributor: fullname: Ware – volume: 10 start-page: e0134001 year: 2015 ident: R55-2-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0134001 contributor: fullname: Johannsen – volume: 60 start-page: 1178 year: 2011 ident: R59-2-20160420 publication-title: Gut doi: 10.1136/gut.2010.234617 contributor: fullname: Bouguen – volume: 19 start-page: 377 year: 1984 ident: R52-2-20160420 publication-title: J Hum Resour. doi: 10.2307/145879 contributor: fullname: Haveman – volume: 105 start-page: 289 year: 2010 ident: R6-2-20160420 publication-title: Am J Gastroenterol. doi: 10.1038/ajg.2009.579 contributor: fullname: Peyrin-Biroulet – volume: 54 start-page: 667 year: 2006 ident: R37-2-20160420 publication-title: J Am Geriatr Soc. doi: 10.1111/j.1532-5415.2006.00681.x contributor: fullname: Dorr – volume: 52 start-page: 1051 year: 1997 ident: R51-2-20160420 publication-title: Am Psychol. doi: 10.1037/0003-066X.52.10.1051 contributor: fullname: Ceci – volume: 142 start-page: 46 year: 2012 ident: R1-2-20160420 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.10.001 contributor: fullname: Molodecky – volume: 1 start-page: 15 year: 2013 ident: R34-2-20160420 publication-title: Front Public Health. doi: 10.3389/fpubh.2013.00015 contributor: fullname: Bombak – volume: 87 start-page: 673 year: 2007 ident: R8-2-20160420 publication-title: Surg Clin North Am. doi: 10.1016/j.suc.2007.03.003 contributor: fullname: Ephgrave – volume: 54 start-page: 477 year: 2012 ident: R15-2-20160420 publication-title: J Pediatr Gastroenterol Nutr. doi: 10.1097/MPG.0b013e318239bc79 contributor: fullname: Heaton – volume: 7 start-page: 375 year: 2005 ident: R27-2-20160420 publication-title: Colorectal Dis. doi: 10.1111/j.1463-1318.2005.00769.x contributor: fullname: Thaler – volume: 11 start-page: 23 year: 1996 ident: R50-2-20160420 publication-title: World Bank Res Observ. doi: 10.1093/wbro/11.1.23 contributor: fullname: Behrman – volume: 158 start-page: 884 year: 2004 ident: R23-2-20160420 publication-title: Arch Pediatr Adolesc Med. doi: 10.1001/archpedi.158.9.884 contributor: fullname: van Dyck – volume: 40 start-page: 1234 year: 2005 ident: R36-2-20160420 publication-title: Health Serv Res. doi: 10.1111/j.1475-6773.2005.00404.x contributor: fullname: DeSalvo – volume: 57 start-page: 3080 year: 2012 ident: R19-2-20160420 publication-title: Dig Dis Sci. doi: 10.1007/s10620-012-2289-y contributor: fullname: Gunnarsson – volume: 58 start-page: 519 year: 2013 ident: R3-2-20160420 publication-title: Dig Dis Sci. doi: 10.1007/s10620-012-2371-5 contributor: fullname: Kappelman – volume: 21 start-page: 1839 year: 2015 ident: R56-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1097/MIB.0000000000000452 contributor: fullname: Koutsochristou – volume: 44 start-page: I54 year: 2006 ident: R38-2-20160420 publication-title: Med Care. doi: 10.1097/01.mlr.0000208141.02083.86 contributor: fullname: Fleishman – volume: 16 start-page: 1603 year: 2002 ident: R25-2-20160420 publication-title: Aliment Pharmacol Ther. doi: 10.1046/j.1365-2036.2002.01323.x contributor: fullname: Cohen – volume: 19 start-page: 2423 year: 2013 ident: R14-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1097/MIB.0b013e3182a56148 contributor: fullname: deBruyn – volume: 59 start-page: 1297 year: 2004 ident: R33-2-20160420 publication-title: Soc Sci Med. doi: 10.1016/j.socscimed.2003.01.001 contributor: fullname: Benjamins – volume: 1 start-page: 207 year: 2003 ident: R54-2-20160420 publication-title: Econ Hum Biol. doi: 10.1016/S1570-677X(03)00035-2 contributor: fullname: Schultz – volume: 50 start-page: 1261 year: 2008 ident: R18-2-20160420 publication-title: J Occup Environ Med. doi: 10.1097/JOM.0b013e318181b8ca contributor: fullname: Gibson – volume: 102 start-page: 2737 year: 2007 ident: R26-2-20160420 publication-title: Am J Gastroenterol. doi: 10.1111/j.1572-0241.2007.01508.x contributor: fullname: Feagan – volume: 126 start-page: 1504 year: 2004 ident: R4-2-20160420 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.01.063 contributor: fullname: Loftus – volume: 21 start-page: 1623 year: 2015 ident: R13-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1097/MIB.0000000000000399 contributor: fullname: Zand – volume: 135 start-page: 1907 year: 2008 ident: R16-2-20160420 publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.09.012 contributor: fullname: Kappelman – volume: 60 start-page: 299 year: 2015 ident: R10-2-20160420 publication-title: Dig Dis Sci. doi: 10.1007/s10620-014-3368-z contributor: fullname: Floyd – volume: 46 start-page: 164 year: 2008 ident: R28-2-20160420 publication-title: J Pediatr Gastroenterol Nutr. doi: 10.1097/MPG.0b013e31812f7f4e contributor: fullname: Perrin – volume: 7 start-page: 322 year: 2013 ident: R7-2-20160420 publication-title: J Crohnʼs Colitis. doi: 10.1016/j.crohns.2013.01.010 contributor: fullname: Burisch – volume: 18 start-page: 2301 year: 2012 ident: R45-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1002/ibd.22916 contributor: fullname: Goodhand – volume: 55 start-page: 393 year: 2013 ident: R24-2-20160420 publication-title: J Occup Environ Med. doi: 10.1097/JOM.0b013e31827cba48 contributor: fullname: Gunnarsson – volume: 106 start-page: 1670 year: 2011 ident: R46-2-20160420 publication-title: Am J Gastroenterol. doi: 10.1038/ajg.2011.142 contributor: fullname: Loftus – volume: 19 start-page: 2768 year: 2013 ident: R58-2-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1097/01.MIB.0000438356.84263.3b contributor: fullname: Vavricka – volume: 161 start-page: 730 year: 2007 ident: R53-2-20160420 publication-title: Arch Pediatr Adolesc Med. doi: 10.1001/archpedi.161.8.730 contributor: fullname: Reynolds – volume: 49 start-page: 284 year: 2014 ident: R40-2-20160420 publication-title: Health Serv Res. doi: 10.1111/1475-6773.12090 contributor: fullname: Dugoff – volume: 155 start-page: 1346 year: 2001 ident: R22-2-20160420 publication-title: Arch Pediatr Adolesc Med. doi: 10.1001/archpedi.155.12.1346 contributor: fullname: Kuhlthau |
SSID | ssj0020209 |
Score | 2.3917675 |
Snippet | Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are diagnosed yearly.... BACKGROUNDApproximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are... Background: Approximately 593,000 to 780,000 people in the United States (US) have been diagnosed with Crohn's disease (CD), and an additional 33,000 are... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1032 |
SubjectTerms | Adolescent Adult Aged Child Child, Preschool Cost of Illness Crohn Disease - economics Crohn Disease - epidemiology Crohn Disease - physiopathology Female Follow-Up Studies Health Care Costs - statistics & numerical data Health Status Humans Infant Infant, Newborn Male Middle Aged Quality of Life Severity of Illness Index Surveys and Questionnaires United States - epidemiology Young Adult |
Title | The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26974852 https://search.proquest.com/docview/1783918332 https://search.proquest.com/docview/1808694669 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDsdFx0kJB6qjMVJHIc3ugsrWoc0Wqlvkd3YDG1LUC9D4okfww_lOI5zQQUN-hBVUVunOV_O-c7VhLxCi0olwyctkEJ7YZglHs_8yPMF43Nf6zhmpt95fMKOpuGHWTTr9X62qpbWK7kz_76xr-R_pIrnUK6mS_YfJFv_KJ7A9yhfPKKE8XhtGbvO4jILYJuKvLJBBZnkqG6B3FsUZ3bzlH2bkXH1jR3OacIDbptR23giBtXg7IuLkqzXzUpXCnXO4qqbFR7lGgF2aRP3svim6gRQzdzfIxdtlesP6tjzp_VnE13PWzJvgv1WIZ0WSzEYn4lGa-ZV_Gi4MHpqqM7Pq2LjKo7hs6ZqsFK9u2bWb2L3pN5RTh0zL-R2QqTT15S2cBm1lK-ZDdgy5Oho-huNhB0-PB4N7fBK94pD2hhFVwhw8jE9nB4fp5OD2eQGuUnjJDIu_v5pPaSM7tpCovr6XYNmEr_ZtEaXAP3BqynZzeQuuVO5JfDOYuwe6an8Prk1rgovHpAfCDVwUAOEGnShBhZqUGgoofZ6CRXQ4EsOCDSwQAMLtLfgYAYGZiCggRl0YQYWZg_J9PBgsnfkVZt3eHP04Vee1BzZPKdKsSiRCt16EQoaxkyZ9jkRSfTNRVCWE3CdBck8CDLNfSUMw89YFjwiW3mRqycEqK-QxqssQW6NJkZz9LFYRMOASy40l33iuTuafrUzWlJXW4ESSH-XQJ-8dLc9RWVqMmQiV8V6mfoxLoRGLvjbZ_B_MbMrQ9Inj63M6lUpQ_ecR3T7Gt9-Sm43j8EzsrVarNVzJLgr-aLE1y_gmaLR |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Economic+and+Health-related+Impact+of+Crohn%27s+Disease+in+the+United+States%3A+Evidence+from+a+Nationally+Representative+Survey&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Ganz%2C+Michael+L&rft.au=Sugarman%2C+Rebecca&rft.au=Wang%2C+Rosa+Mha&rft.au=Hansen%2C+Brian+Bekker&rft.date=2016-05-01&rft.issn=1078-0998&rft.eissn=1536-4844&rft.volume=22&rft.issue=5&rft.spage=1032&rft.epage=1041&rft_id=info:doi/10.1097%2FMIB.0000000000000742&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon |